Ameritas Investment Partners’s Cartesian Therapeutics RNAC Stock Holding History

Ameritas Investment Partners’s Portfolio RNAC Stock Details RNAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.35K	Hold	708	–	–	﹤0.01%	3009
2025 Q4	$5.11K	Hold	708	–	–	﹤0.01%	3025
2025 Q3	$7.24K	Hold	708	–	–	﹤0.01%	3007
2025 Q2	$7.36K	Hold	708	–	–	﹤0.01%	3049
2025 Q1	$9.33K	Hold	708	–	–	﹤0.01%	2842
2024 Q4	$12.7K	Hold	708	–	–	﹤0.01%	2836
2024 Q3	$11.4K	Hold	708	–	–	﹤0.01%	2880
2024 Q2	$19.1K	Buy	708 +388	+121%	+$9.26K	﹤0.01%	2637
2024 Q1	$6.23K	Hold	320	–	–	﹤0.01%	2917
2023 Q4	$6.61K	Hold	320	–	–	﹤0.01%	2931
2023 Q3	$10.2K	Hold	320	–	–	﹤0.01%	2834
2023 Q2	$10.7K	Buy	+320	New	+$11.5K	﹤0.01%	2889
2022 Q2	–	Sell	-200	Closed	-$7K	–	3207
2022 Q1	$7K	Hold	200	–	–	﹤0.01%	2897
2021 Q4	$20K	Hold	200	–	–	﹤0.01%	2652
2021 Q3	$25K	Hold	200	–	–	﹤0.01%	2582
2021 Q2	$25K	Hold	200	–	–	﹤0.01%	2628
2021 Q1	$27K	Hold	200	–	–	﹤0.01%	2433
2020 Q4	$18K	Hold	200	–	–	﹤0.01%	2525
2020 Q3	$15K	Hold	200	–	–	﹤0.01%	2533
2020 Q2	$17K	Buy	+200	New	+$18.1K	﹤0.01%	2433
2019 Q2	–	Sell	-34	Closed	-$2K	–	3098
2019 Q1	$2K	Hold	34	–	–	﹤0.01%	2952
2018 Q4	$3K	Hold	34	–	–	﹤0.01%	2914
2018 Q3	$16K	Hold	34	–	–	﹤0.01%	2626
2018 Q2	$14K	Hold	34	–	–	﹤0.01%	2705
2018 Q1	$10K	Hold	34	–	–	﹤0.01%	2732
2017 Q4	$10K	Hold	34	–	–	﹤0.01%	2754
2017 Q3	$18K	Hold	34	–	–	﹤0.01%	2488
2017 Q2	$20K	Buy	34 +20	+143%	+$8.83K	﹤0.01%	2453
2017 Q1	$6K	Buy	+14	New	+$5.89K	﹤0.01%	2815

Other funds holding RNAC

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameritas Investment Partners's RNAC Position: Q1 2026 in Review

Ameritas Investment Partners held its Cartesian Therapeutics (RNAC) position steady in Q1 2026 at 708 shares worth $4.35K. The position accounts for ﹤0.01% of the portfolio, ranked #3009.

Ameritas Investment Partners first reported a position in RNAC in Q1 2017 and has held it in 29 quarters since. The position peaked at $27K in Q1 2021. 83 funds tracked by Wall St. Rank hold RNAC as of Q1 2026.

Ameritas Investment Partners held 708 shares of Cartesian Therapeutics worth $4.35K as of Q1 2026.
Ameritas Investment Partners left its Cartesian Therapeutics share count unchanged in Q1 2026.
Cartesian Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #3009 holding.
Ameritas Investment Partners first reported a position in Cartesian Therapeutics in Q1 2017 and has held it in 29 quarters since.
Ameritas Investment Partners's Cartesian Therapeutics position peaked at $27K in Q1 2021.
83 funds tracked by Wall St. Rank held Cartesian Therapeutics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.